These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 11343045
1. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. Simons FE, Villa JR, Lee BW, Teper AM, Lyttle B, Aristizabal G, Laessig W, Schuster A, Perez-Frias J, Sekerel BE, Menten J, Leff JA. J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045 [Abstract] [Full Text] [Related]
2. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE. J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871 [Abstract] [Full Text] [Related]
7. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Maspero JF, Dueñas-Meza E, Volovitz B, Pinacho Daza C, Kosa L, Vrijens F, Leff JA. Curr Med Res Opin; 2001 Aug; 17(2):96-104. PubMed ID: 11759189 [Abstract] [Full Text] [Related]
8. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial. Kumar V, Ramesh P, Lodha R, Pandey RM, Kabra SK. J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754 [Abstract] [Full Text] [Related]
9. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma. Stelmach I, Bobrowska-Korzeniowska M, Majak P, Stelmach W, Kuna P. Pulm Pharmacol Ther; 2005 Oct; 18(5):374-80. PubMed ID: 15939317 [Abstract] [Full Text] [Related]
16. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA. Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [Abstract] [Full Text] [Related]
17. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. Leigh R, Vethanayagam D, Yoshida M, Watson RM, Rerecich T, Inman MD, O'Byrne PM. Am J Respir Crit Care Med; 2002 Nov 01; 166(9):1212-7. PubMed ID: 12403690 [Abstract] [Full Text] [Related]
18. The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction. Duong M, Amin R, Baatjes AJ, Kritzinger F, Qi Y, Meghji Z, Lou W, Grasemann H, O'Byrne PM, Subbarao P. J Allergy Clin Immunol; 2012 Aug 01; 130(2):535-9.e3. PubMed ID: 22534533 [No Abstract] [Full Text] [Related]